PBAC Public Summary Documents - March 2015

Page last updated: 6 January 2016

Public Summary Documents relating to the March PBAC meeting.

• Aflibercept; 4 mg/0.1 mL injection, 1 x 0.1 mL vial, 4 mg/0.1 mL injection, 1 x 0.09 mL syringe; Eylea®
• Amino acid formula with vitamins and minerals without phenylalanine, oral liquid, 30 x 130 mL & 30 x 174 mL pouch, PKU Air®
• Amino acid formula with vitamins and minerals without valine, leucine and isoleucine, oral liquid: powder for, 30 x 36 g sachets, MSUD Anamix Junior®;
• Amino acid formula with vitamins and minerals without phenylalanine, oral liquid: powder for, 30 x 36 g sachets, PKU Anamix Junior®;
• Amino acid formula with vitamins and minerals without phenylalanine and tyrosine, oral liquid: powder for, 30 x 36 g sachets, TYR Anamix Junior®
• Amino acid formula with vitamins and minerals without lysine and low in tryptophan; oral liquid: powder for, 500 g; XLYS LOW TRY Maxamum®
• Amino acid synthetic formula; oral liquid: powder for, 400 g; Alfamino® Junior
• Anti-Glaucoma drugs; (various)
• Apixaban; 2.5 mg tablet 60, 5 mg tablet 28, 5 mg tablet 60; Eliquis®  
• Apremilast; 30 mg tablet 56, Starter Pack (10 mg tablet 4; 20 mg tablet 4; and 30 mg tablet 19); Otezla®
• Apremilast; 30 mg tablet 56, Starter Pack (10 mg tablet 4; 20 mg tablet 4; and 30 mg tablet 19); Otezla®
• Asunaprevir; 100 mg capsule 56; Sunvepra®
• Bendamustine Hydrochloride; 25 mg injection: powder for, 1 vial, 100 mg injection: powder for, 1 vial; Ribomustin®
• Brentuximab Vedotin; 50 mg injection: powder for, 1 vial; Adcetris®
• Buprenorphine; 15 microgram/hour patch 2, 25 microgram/hour patch 2,30 microgram/hour patch, 2,40 microgram/hour patch, 2; Norspan®
• Canakinumab; 150 mg injection: powder for, 1 vial, 150 mg injection: powder for, 4 vials; Ilaris®
• Daclatasvir; 60mg or 30mg, tablets; Daklinza®
• Dapagliflozin; 10 mg tablet 28; Forxiga®
• Dexamethasone; 700 µg implant; Ozurdex®
• Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (DTPa-HepB-IPV-Hib); 0.5 mL pre-filled syringe; Hexaxim®
• Etanercept; 50 mg injection in 1mL single use auto-injector, 4 pack 50 mg injection in 1 mL single use pre-filled syringes, 4 pack 25 mg injection [4 x 25 mg vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack; Enbrel®
• Evolocumab; 140 mg/1 mL injection, 1 x 1 mL injection device; Repatha®
• Exenatide; 5 microgram/0.02 mL injection: solution, 60 unit doses 10 microgram/0.04 mL injection: solution, 60 unit doses; Byetta®
• Febuxostat; 80 mg tablet 28, 120 mg tablet 28; Adenuric®
• Follitropin alfa (rch) + lutropin alfa (rch); follitropin alfa (rch) 150 IU + lutropin alfa (rch) 75 IU injection; Pergoveris®
• Glatiramer; 40 mg/mL injection, 12 x 1 mL syringes; Copaxone 40®
• Glycomacropeptide and essential amino acids with vitamins and minerals; oral liquid, 28 x 250 mL cartons, oral liquid, 28 x 250 mL cartons; PKU Glytactin® RTD and 10 PKU Glytactin® RTD 15
• Idelalisib; 100 mg tablet 60, 150 mg tablet 60; Zydelig®
• Idelalisib; 100 mg tablet 60, 150 mg tablet 60; Zydelig®
• Imatinib; 100 mg tablet 56, 400 mg tablet 28; Glivec®
• Influenza Vaccine (quadrivalent); 0.5 mL pre-filled syringe; Fluarix tetra®
• Insulin Glargine; 100 international units/mL injection, 5 x 3 mL cartridges; Basaglar®, Basaglar KwikPen®
• Ivabradine; 5 mg tablet 56, 7.5 mg tablet 56; Coralan®
• Lacosamide; 50 mg tablet; Vimpat®
• Ledipasvir with sofosbuvir; ledipasvir 90 mg + sofosbuvir 400 mg tablet 28; Harvoni®
• Lignocaine; 5% patch: dermal, 30; Versatis®
• Lurasidone hydrochloride; 40 mg tablet 30, 80 mg tablet 30; Latuda®
• Lutropin alfa; 75 IU injection [1 x 75 IU vial] (&) inert substance diluent [1 x 1 mL vial], 1 pack; Luveris®
• Netupitant with Palonosetron; netupitant 300 mg + palonosetron 500 microgram capsule 1; Akynzeo®
• Nintedanib, 100 mg capsule, 60; 150 mg capsule, 60; Ofev®
• Nintedanib, 100 mg capsule, 60; 150 mg capsule, 60; Ofev®
• Obinutuzumab; 1 g/40 mL injection, 40 mL vial; Gazyva®
• Oxycodone hydrochloride; modified release tablet, 5 mg; Oxycodone Sandoz®
• Oxycodone hydrochloride + naloxone modified release tablet, 2.5 mg/1.25 mg, 15 mg/7.5 mg, and 30mg/15 mg; Targin®
• Panitumumab; 100 mg/5 mL injection, 1 x 5 mL vial, 400 mg/20 mL injection, 1 x 20 mL vial; Vectibix®
• Pembrolizumab; 50 mg injection: powder for, 1 vial, 100 mg injection: powder for, 1 vial; Keytruda®
• Pneumoccal polysaccharide conjugate vaccine (13-valent), 0.5 mL injection; Prevenar 13®
• Posaconazole; 100 mg modified release tablet; Noxafil®
• Propanolol; 3.75 mg/mL oral liquid,2 x 120 mL; Hemangiol®
• Regorafenib; 40 mg tablet 84; Stivarga®
• Ribavirin; 400 mg tablet 28, 600 mg tablet 28, Ibavyr®
• Rituximab; 500 mg/50 mL injection: 1 x 50 mL vial; MabThera®
• Ruxolitinib; 5 mg tablet 56, 15 mg tablet 56, 20 mg tablet 56; Jakavi®
• Secukinumab; 150 mg injection: powder for, 1 vial, 150 mg/1 mL injection: solution, 1 mL injection device, 150 mg/1 mL injection: solution, 1 mL syringe; Cosentyx®
• Sofosbuvir; 400 mg tablet 28, Sovaldi®
• Sorafenib; 200 mg tablet 60; Nexavar®
• Testosterone; 1% gel, 2 x 88 g pump packs; Testogel®
• Testosterone; 50 mg/mL cream, 50 mL; AndroForte® 5
• Tofacitinib; 5 mg tablet 56; Xeljanz®
• Triglycerides medium chain formula; triglycerides medium chain oral liquid, 8 x 500 mL cartons; Nutrini Peptisorb®
• Vedolizumab; 300 mg injection: powder for, 1 vial; Entyvio®
• Vedolizumab; 300 mg injection: powder for, 1 vial; Entyvio®